Next quarters cash burn will be telling. Conservatively we want our cash balance to cover 4 times whatever the cash burn is plus leave a healthy residual for unforseen expenses. Any additional investment will require a cap raise. I reckon vax development will be mothballed for a year till we get on our feet. Would be great to sell/partner it but i fear we are in a very weak negotiating position.
Ann: Annual Report to shareholders, page-63
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.01 |
Change
0.010(0.06%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.81 | $18.34K | 1.018K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13 | $18.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.18 | 21 | 2 |
View Market Depth
| Last trade - 11.48am 08/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |